AMERIPRISE FINANCIAL INC

Position in OCGN — Ocugen, Inc.

CIK 820027 MINNEAPOLIS, MN

Position in OCGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$28,688

+$7,662 QoQ

Shares Held

15,850

+1.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

AMERIPRISE FINANCIAL INC holds $4,148,963,810 across 191 Biotechnology names. OCGN ranks #182 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,633,481	$1,175,954,605
2	INSM	INSMED Inc	3,057,718	$499,998,047
3	JAZZ	Jazz Pharmaceuticals plc	1,608,476	$304,082,387
4	REGN	Regeneron Pharmaceuticals, Inc.	319,677	$246,995,237
5	ARGX	Argenx SE	215,910	$157,668,275
6	RVMD	Revolution Medicines, Inc.	1,579,793	$153,634,869
7	ASND	Ascendis Pharma A/S	476,466	$108,982,067
8	BBIO	BridgeBio Pharma, Inc.	1,248,521	$92,715,166

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$28,688	15,850	+1.8%	Shares	Defined	2026-05-15
2025-12-31	$21,026	15,575	-59.1%	Shares	Defined	2026-02-17
2025-03-31	$26,900	38,102	+1.5%	Shares	Defined	2025-05-14
2024-12-31	$30,223	37,545	+5.0%	Shares	Defined	2025-02-14
2022-12-31	$46,484	35,758	-0.3%	Shares	Defined	2023-02-14
2022-09-30	$63,809	35,848	-18.6%	Shares	Defined	2022-11-14
2022-06-30	$99,988	44,048	-11.3%	Shares	Defined	2022-08-15
2022-03-31	$163,887	49,663	-3.3%	Shares	Defined	2022-05-16
2021-12-31	$233,747	51,373	-40.9%	Shares	Defined	2022-02-14
2021-09-30	$623,640	86,858	+6.5%	Shares	Defined	2021-11-15
2021-06-30	$654,910	81,558	+229.4%	Shares	Defined	2021-08-16
2021-03-31	$168,106	24,758	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.